Business Context and Reporting Period
This Form 8-K was filed by Tevogen Bio Holdings Inc. (now Tevogen Inc.) on July 29, 2026. The report details a corporate name change and corresponding amendments to the company's governing documents.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes and does not contain financial performance data.
Material Changes
- Name Change: The company changed its name from "Tevogen Bio Holdings Inc." to "Tevogen Inc." effective July 30, 2026.
- Governing Documents: The Board of Directors approved amendments to the Certificate of Incorporation and the Amended and Restated Bylaws to reflect the new name.
- Trading Symbols: Common stock and public warrants continue to trade on the Nasdaq Global Market under the ticker symbols "TVGN" and "TVGNW," respectively.
- Security Identifiers: The CUSIP numbers for common stock (88165K200) and public warrants (88165K119) remain unchanged.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report explicitly states that the name change does not affect the rights of the company's security holders.
Key Facts for Investor Verification
- Verify the effective date of the name change (July 30, 2026) in corporate registries.
- Confirm that trading symbols (TVGN, TVGNW) and CUSIP numbers remain unchanged on the Nasdaq Global Market.
- Review the attached Certificate of Amendment (Exhibit 3.1) and Amended and Restated Bylaws (Exhibit 3.2) for any clauses beyond the name change.
- Ensure no other material changes to the company's capital structure or operations were disclosed in this specific filing.